Zug, Switzerland
HBM Partners is among the global leaders in healthcare-focused investing with over $1 billion in assets under management. HBM focuses on development-stage, growth and buy-out financings of private companies as well as investments in public companies. HBM Partners advises HBM Healthcare Investments, HBM BioCapital I and II, as well as further specialized private-equity and public-equity funds. HBM has a complementary team of experienced professionals to source, evaluate, execute and exit investments in the pharma/biotech, medical device and diagnostics industries. We have been an active contributor to value creation in our portfolio companies, generating over 50 trade sales and IPOs since 2001. Visit our website at:
38
Total Investments
29
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Biotechnology, Financial Services
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About HBM Partners
Recent Investments (38)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series D | •••••• | Aug 2023 | |
| Series A | •••••• | Jun 2023 | |
| Convertible Note | •••••• | Jun 2023 | |
| Convertible Note | •••••• | May 2023 | |
| Series E | •••••• | Apr 2023 | |
•••• ••••
|
Convertible Note | •••••• | Apr 2023 |
|
•••• ••••
|
Series B | •••••• | Mar 2023 |
|
•••• ••••
|
Convertible Note | •••••• | Oct 2022 |
|
•••• ••••
|
Series D | •••••• | May 2022 |
|
•••• ••••
|
Series B | •••••• | Apr 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
